Sulfonylureas and Insulin : Co-administration with sulfonylurea drugs (e.g., glimepiride) or insulin increases the risk of hypoglycemia
We also found that reduced level of LDH in the LC group
All existing prior authorizations for weight-loss treatments will be canceled, though coverage for GLP-1 medications prescribed for Type 2 diabetes will continue
Peptides are short chains of amino acids that signal specific biological actions in the body, such as enhancing growth hormone release, supporting tissue repair, or boosting the immune system
Most commonly, these include gastrointestinal disorders, including: Nausea Stomach pain Diarrhoea Vomiting Constipation Due to the nature of weight loss medications, these side effects are common and tend to resolve with time, once your body is used to the medication
With these drugs, the main side effects are nausea, vomiting, constipation, diarrhea, and other gastrointestinal issues